We are pleased to welcome Vertitas Corporation as a new distributor of the Devyser portfolio for...
Relapse of the underlying malignant disease is a major complication after hematopoietic stem cell...
Time is precious. Every minute, every second that we can simplify your lab’s workflow shortens the...
Conventional genetic testing for thalassemia requires the use of several techniques, leading to...
"Devyser reports yet another quarter of record sales and strong gross margins. The positive sales...
Devyser announces its decision to establish a CLIA lab in Atlanta, Georgia, USA. By operating a...
Growth. We are building for growth and consequently, we are excited to announce the launch of our...
We are very happy to announce that TÜV SÜD has verified the update of our quality management system...
Early non-invasive prenatal testing (NIPT) for fetal Rhesus D (RHD) status is playing an...
MSS, Mexico’s largest public health care provider and INP, Mexico’s National Institute of...
Stockholm, February 2, 2021
